Involvement of monoaminergic and peptidergic components in cathinone-induced analgesia.
Evidence has been obtained suggesting that cathinone-induced analgesia depends upon stimulation of alpha-adrenoceptors, followed by release of opioid peptides and by activation of serotonergic pathways. This hypothesis is supported by the following. (1) Cathinone potentiated morphine analgesia and the whole effect was antagonized by naloxone whereas onto the cathinone potentiation was counteracted by phenoxybenzamine. (2) Bestatin potentiated cathinone-induced analgesia and this effect was sensitive to both naloxone and phenoxybenzamine blockade. (3) The analgesic effect of cathinone + bestatin was further potentiated by the serotonin uptake inhibitor citalopram.
D000470:Alkaloids / Q000494:pharmacology*; D000700:Analgesics; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology*; D004723:Endorphins / Q000502:physiology*; D008297:Male; D051379:Mice; D009270:Naloxone / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011619:Psychotropic Drugs / Q000494:pharmacology*
D000470:Alkaloids; D000700:Analgesics; D001679:Biogenic Amines; D004723:Endorphins; D011619:Psychotropic Drugs; D010643:Phenoxybenzamine; D009270:Naloxone; C023665:cathinone